A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis-Reference-Cited by-同舟云学术

A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis

Published:2020-11 Issue:10 Volume:8 Page:3500-3506
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Ungar Benjamin,Pavel Ana B.,Robson Philip M.,Kaufman Audrey,Pruzan Alison,Brunner Patrick,Kaushik Shivani,Krueger James G.,Lebwohl Mark G.,Mani Venkatesh,Fayad Zahi A.,Guttman-Yassky Emma

Funder

NIH

Pfizer

Amgen

Janssen

Lilly

Merck

Novartis

Kadmon

Dermira

Boehringer

Innovaderm

Kyowa

BMS

Serono

Biogen Idec

Delenex

AbbVie

Sanofi

Baxter

Parexel

Xenoport

Kineta

Arcutis

AstraZeneca

Boehringer Ingelheim

Celgene

Clinuvel

Eli Lilly

Incyte

Janssen Research & Development

LLC

Kadmon Corp.

Leo Pharmaceuticals

MedImmune

Ortho Dermatologics

Sciderm

UCB

Daiichi-Sankyo

Bristol Myers Squibb

Siemens Healthineers

AnaptysBio

AntibioTx

Asana Bioscience

DBV

Dermavant

DS Biopharma

Galderma

Glenmark

Janssen Biotech

Kiniska Pharma

LEO Pharmaceuticals

Sienna Biopharmaceuticals

Novan

Ralexar

Regeneron

Union Therapeutics

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference45 articles.

1. A population-based survey of eczema prevalence in the United States;Hanifin;Dermatitis,2007

2. Persistence of mild to moderate atopic dermatitis;Margolis;JAMA Dermatol,2014

3. Persistence of childhood eczema into adulthood;Silverberg;JAMA Dermatol,2014

4. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder;Brunner;J Invest Dermatol,2017

5. Eczema and cardiovascular risk factors in 2 US adult population studies;Silverberg;J Allergy Clin Immunol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure;American Journal of Clinical Dermatology;2024-06-18

2. Atopic Dermatitis and Internal Vessel Inflammation;Clinical Cases in Dermatology;2024

3. Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition;Allergy;2023-07-16

4. Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography;Acta Dermato-Venereologica;2023-05-22

5. Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: A retrospective cohort study;PLOS ONE;2022-11-17